ESSA Pharma (EPIX) Earnings Date, Estimates & Call Transcripts $1.75 0.00 (0.00%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends ESSA Pharma Latest Earnings SummaryUpcoming Q1 Earnings DateFeb. 11Before Market OpensEstimatedActual EPS (Dec. 17) -$0.14 Beat By $0.05 Consensus EPS (Dec. 17) -$0.19 ESSA Pharma released Q4 2024 earnings on December 17, 2024, reporting an EPS of -$0.14, which beat the consensus estimate of -$0.19 by $0.05. With a trailing EPS of -$0.64, ESSA Pharma's earnings are expected to grow next year, from ($0.47) to ($0.29) per share. EPIX Upcoming EarningsESSA Pharma's next earnings date is estimated for Tuesday, February 11, 2025, based off prior year's reporting schedules. Get ESSA Pharma Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on ESSA Pharma and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataEPIX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.EPIX Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. ESSA Pharma Analyst EPS EstimatesCurrent Year EPS Consensus Estimate:($0.47) EPSNext Year EPS Consensus Estimate: ($0.29) EPS ESSA Pharma Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 2/11/2025(Estimated)-------12/17/2024Q4 2024-$0.19-$0.14+$0.05-$0.14--8/5/2024--$0.26-$0.16+$0.10-$0.16--5/14/2024Q2 2024-$0.19-$0.20 -$0.01-$0.20--2/13/2024Q4 2023-$0.17-$0.14+$0.03-$0.14--12/12/2023Q3 2023-$0.22-$0.12+$0.10-$0.12--8/8/2023Q3 2023-$0.20-$0.17+$0.03-$0.17--5/9/2023Q2 2023-$0.20-$0.16+$0.04-$0.16--2/7/2023Q1 2023-$0.24-$0.15+$0.09-$0.15-- ESSA Pharma Earnings - Frequently Asked Questions When is ESSA Pharma's earnings date? ESSA Pharma has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, February 11th, 2025 based off last year's report dates. Learn more on EPIX's earnings history. Did ESSA Pharma beat their earnings estimates last quarter? In the previous quarter, ESSA Pharma (NASDAQ:EPIX) reported ($0.14) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.19) by $0.05. Learn more on analysts' earnings estimate vs. EPIX's actual earnings. How much profit does ESSA Pharma generate each year? ESSA Pharma (NASDAQ:EPIX) has a recorded net income of -$28.54 million. EPIX has generated -$0.64 earnings per share over the last four quarters. What is ESSA Pharma's EPS forecast for next year? ESSA Pharma's earnings are expected to grow from ($0.47) per share to ($0.29) per share in the next year. More Earnings Resources from MarketBeat Related Companies BTMD Earnings TNGX Earnings ATYR Earnings ITOS Earnings TRVI Earnings DSGN Earnings AVIR Earnings AQST Earnings RZLT Earnings CCCC Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Why Amazon’s Next Earnings Could Trigger a Stock BreakoutS&P 500 Earnings Set to Shine: January's Critical Market TestCiena Rebounds: AI and Strong Guidance Drive Post-Earnings SurgeHistory Hints at a Rebound for Toll Brothers After EarningsAlibaba Stock: Why Earnings Make It a Buy Despite the Recent DipMercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead? This page (NASDAQ:EPIX) was last updated on 1/20/2025 by MarketBeat.com Staff From Our PartnersBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMust-See: 5-Second Trump PredictionPresident Trump's prediction is about to become a reality... Opening a rare window of opportunity for you t...InvestorPlace | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredWarren Buffett Bets $40 Billion—You Can Get in for $20I call it "The Last Retirement Stock You'll Ever Need." Warren Buffett himself owns $40 billion of stock in...Behind the Markets | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ESSA Pharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ESSA Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
